DENVER, CO, Nov. 5 /CNW Telbec/ - Medical International Technology Inc.
(MDLH. PK) (http://www.mitcanada.ca http://www.mitinvest.ca), is pleased to
announce that it has received a Non-Refundable deposit of 1.3 Million Dollars
for the worldwide rights to market and sell all of Medical International
Technology Inc.'s present and future Needle-Free Jet-Injectors for the human
and animal markets. This deposit is part of an agreement under negotiation,
which will be disclosed when finalized.
Over the past 12 months, "MIT" has consolidated its efforts, has
significantly strengthened its team and has reorganized its marketing/sales
departments and financial bases in anticipation of its future growth. The
results achieved will be reflected during the 2007 / 2008 fiscal year.
Medical International Technology Inc. is in negotiations with major
worldwide distributors and possible Joint-Venture partners in different
countries around the world for its present and future Jet Injector products in
the human and animal fields.
Medical International Technology Inc. is pleased to continue providing a
safe and effective means to help prevent the spread of deadly diseases to both
humans and animals through the use of the MED-JET(R) and AGRO-JET(R)
needle-free injection systems.
Medical International Technology Inc. also announces its filling of the
September 30, 2006 fiscal year-end 10K.
Karim Menassa, President
On Behalf of the Board of Directors
About Medical International Technology, Inc.
MIT CANADA, with offices in Montreal, is a subsidiary of Denver,
Colorado-based Medical International Technology, Inc. (MIT USA), which
specializes in the development, production, marketing and sale of needle-free
injectors both for humans and animals, for individual and mass vaccinations.
The statements which are not historical facts contained in this press
release are forward-looking statements that involve certain risks and
uncertainties, including but not limited to risks associated with the
uncertainty of future financial results, additional financing requirements,
development and acquisition of new product lines and services, government
approval processes, the impact of competitive products or pricing a
technological changes, the effect of economic conditions and other
uncertainties, and the risk factors set forth from time to time in the
Company's SEC reports, including but not limited to its annual report on Form
10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K.
Medical International Technology Inc. takes no obligation to update or correct
For further information:
For further information: Karim Menassa, President, (514) 339-9355,